Skip to main content
FoodRecallWatch
Class III, Unlikely HarmfulF-0816-2014

LipiChol 540 (Omega-3 Phospholipid) Medical Food Dispense by Prescription Distributed by: PharmaceutiX Orlando, Florida

Recalled by Atlantic Pro Nutrients, INC. DBA Xymogen on Aug 16, 2013

Reviewed by FoodRecallWatch Editorial Team · Updated

Recall Summary

Atlantic Pro Nutrients, INC. DBA Xymogen recalled LipiChol 540 (Omega-3 Phospholipid) Medical Food Dispense by Prescription Distributed by: PharmaceutiX Orlando, Florida in a Class III action, the FDA tier used when a product is unlikely to cause adverse health effects, typically for labeling or minor regulatory issues on Aug 16, 2013.

The FDA-published reason for this recall is: "Product was labeled as a medical food as opposed to a dietary supplement."

Distribution was broad: the FDA record describes it as "Nationwide and Alaska Canada and China," which places this among the wider-reach recalls on the site. Consumers across the affected area should check product on hand. The recalling firm is based in Orlando, FL. The recall covers 25,852 bottles (All Brands) of product. The FDA has Terminated this recall (first reported Jan 8, 2014), its final lifecycle state, indicating the agency considers the corrective action resolved. The historical record remains useful for tracking a brand's recall pattern over time.

Reason for Recall

Product was labeled as a medical food as opposed to a dietary supplement.

Product Description

LipiChol 540 (Omega-3 Phospholipid) Medical Food Dispense by Prescription Distributed by: PharmaceutiX Orlando, Florida

Distribution

Nationwide and Alaska Canada and China

What Should You Do?

  • 1.Check your kitchen for this product immediately.
  • 2.Do not consume the recalled product.
  • 3.Return the product to where you bought it for a full refund, or throw it away.
  • 4.If you have experienced any health issues, contact your healthcare provider.

Browse Related Recalls

Terms Explained

Source: FDA Recalls, Market Withdrawals and Safety Alerts, 2026.